[31-302-am] Risk management

Sun. Mar 31, 2024 8:30 AM - 9:18 AM [Room 302] Conference Center 302 (3F)

Chair: Ayumu Nagamine, Daiki Hira

+Add all to schedule

8:30 AM - 8:42 AM

[31-302-am01S] Nationwide Survey on Collection and Analysis of Medication-Related Incident Reports in Hospitals

○Sayaka Ebara¹, Hayato Kizaki¹, Shungo Imai¹, Osamu Yasumuro², Ryohkan Funakoshi², Satoko Hori¹ (1. Keio Univ. Pharm., 2. Department of Pharmacy, Kameda General Hospital)

8:42 AM - 8:54 AM

[31-302-am02] The research on fracture rates before and after pembrolizumab

○TAKAO TOBE¹, NOBUYUKI FUJITA¹, TOMOHIRO MIZUNO¹, SHIGEKI YAMADA¹ (1. Sch. Med., Fujita Health Univ.)

8:54 AM - 9:06 AM

[31-302-am03] A cross-sectional survey of hepatitis B virus screening in patients who received immunosuppressive therapy for rheumatoid arthritis in Japan

○Yuki Yanagisawa¹, Shungo Imai¹, Hayato Kizaki¹, Satoko Hori¹ (1. Keio Univ. Pharm.)

9:06 AM - 9:18 AM

[31-302-am04] Survey on medical safety at community pharmacies in oral drug therapy for COVID-19 infection

○Masahisa Kato¹, Sadaharu Yoshino¹, Yuki Inoue¹, Shuhei Konishi¹, Nao Kondo¹, Keiko Haraguchi¹, Masayuki Takeno¹, Atsushi Washiyama¹, Junichi Takaki¹, Taro Kihara¹ (1. Fukuoka City Pharmacy Association)